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Nonprotein-bound Iron in Postasphyxial Reperfusion Injury of the
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ABSTRACT. Objective. To investigate if the avail­
ability of nonprotein-bound iron after birth asphyxia is 
related to the severity of the postasphyxial injury and 
neurodevelopmental outcome.
Methods. Nonprotein-bound iron (bleomycin assay) 
and thiobarbituric-acid-reactive species, an index of oxida­
tive lipid damage, were measured in plasma of 50 newborn 
infants (gestational age >34 weeks) between 0 to 8 hours, 8 
to 16 hours, and 16 to 24 hours after birth. Three groups 
were compared: healthy infants (n = 20), moderately as­
phyxiated infants (n = 15), who were neurologically normal 
during the first 24 hours after birth and severely asphyxi­
ated infants (n = 15), who developed abnormal neurologi­
cal signs in the first 24 hours after birth.
Results. In the severely asphyxiated infants, liver en­
zymes, creatinine, urea, and uric acid concentrations were 
significantly elevated. Eleven severely asphyxiated in­
fants were brain-damaged, 9 of them died during the 
neonatal period. Nonprotein-bound iron was detectable 
in 30% of the control, 60% of the moderately asphyxiated, 
and 80% of the severely asphyxiated infants. During the 
whole study period nonprotein-bound iron concentra­
tion was significantly elevated in severely asphyxiated 
infants as compared with controls. Three of the four 
severely asphyxiated infants who had a normal outcome 
at 1 year of age, had no detectable nonprotein-bound iron 
during the study period. Stepwise logistic regression 
analysis with neurodevelopmental outcome at 1 year of 
age (normal versus adverse/death) as dependent variable 
and all the measured parameters for organ damage as 
independent variables revealed that the nonprotein- 
bound iron concentration at 0 to 8 hours after birth was 
the most significant variable and at the same time the 
only variable that entered the model, in relation to neu­
rodevelopmental outcome. Thiobarbituric-acid-reactive 
species tended to be higher in severely asphyxiated in­
fants, suggesting oxidative lipid damage.
Conclusion. Nonprotein-bound iron may play an im­
portant role in oxidative damage-mediated postasphyxial 
brain injury and subsequent neurodevelopmental out­
come. Pediatrics 1996;98:883-889; nonprotein-'bound iron, 
birth asphyxia, reperftision injury, newborn.
ABBREVIATIONS. H20 2/ hydrogen peroxide; LDH, lactic acid 
dehydrogenase; 0 2*/ superoxide; OH\ hydroxyl radical; SGOT, 
serum glutamic oxaloacetic transaminase; SGPT, serum glutamic 
pyruvic transaminase; TBARS, thiobarbituric-acid-reactive spe­
cies.
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Despite advances in perinatal and obstetric care, 
perinatal asphyxia is still the m ost im portant cause of 
brain injury in the new born .1'2 A lthough cerebral 
injury may occur during the actual hypoxic-ischemic 
insult, recent studies suggest that a substantial 
proportion of the injury can be attributed to the 
formation of excess reactive oxygen species on reoxy­
genation and reperfusion .3'4 The preceding hypoxic- 
ischemia induces the brain to respond on reperfusion 
w ith an increased production of reactive oxygen spe­
cies, such as superoxide (0 2*) and hydrogen perox­
ide (H20 2).3“6 Large am ounts of 0 2* and H20 2 are 
generated on reoxygenation by mitochondria, calci­
um-induced production of prostaglandins,7 activated 
neutrophils and macrophages, and by circulating 
xanthine oxidase.8 A lthough relatively poorly reac­
tive themselves, 0 2* and H 20 2 can be converted into 
the highly reactive hydroxyl radical (OH*) by tran­
sition metal ions, in particular nonprotein-bound 
iron, leading to cellular dam age (eg, protein and 
lipid-peroxidation).9 In norm al adults this process is 
prevented by sequestrating iron into safe forms; eg, 
'oy transferrin-binding, which makes nonprotein- 
bound iron undetectable in norm al plasm a.10 Recent 
studies from our group11 and others,12 however, 
showed that up  to 25% of apparently  healthy infants 
had detectable nonprotein-bound iron in their 
plasma. This may im ply that new born infants are 
especially susceptible to oxidative damage as can 
occur during ischemia-reperfusion. The aim of this 
study was therefore to investigate if nonprotein- 
bound iron w as detectable after b irth  asphyxia and 
whether its concentration was associated with the 
severity of the postasphyxial injury and subsequent 
neurodevelopm ental outcome.
METHODS
The study population consisted of 50 infants with a gestational 
age of 35 weeks or more, who consecutively were admitted to our 
neonatal unit for birth asphyxia or for observation (see also be­
low). Thirty patients suffered from birth asphyxia, defined as fetal 
distress (abnormal heart rate pattern, meconium-stained amniotic 
fluid, and a cord or first capillary pH of less than 7.1), requiring 
immediate assisted ventilation for more than 2 minutes. These 
infants were divided into a moderately asphyxiated group (n = 
15), without neurologic abnormalities during the first 24 hours 
after birth and a severely asphyxiated group (n = 15), who sub­
sequently developed neurologic abnormalities during the first 24 
hours after birth (eg, disturbances in consciousness, hypotonia, 
hypo-, or areflexia including weak or absent suck or Moro re­
flexes) and/or convulsions. Transient hyper alertness or hyperre- 
flexia were not considered to be neurologic abnormalities. Twenty 
healthy infants served as a control group. Assignment to the 
moderately or severely asphyxiated group was done within the
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first 24 hours of life and before the results of the various blood 
samples (ie, nonprotein-bound iron, thiobarbiturioacid-reactive 
species, [TBARS], liver and renal function tests, see also below) 
were available. Most of these control infants were admitted for 
observation foT possible infection (premature rupture of mem­
branes, maternal fever), which was eventually excluded, or for 
observation for hypoglycemia because of maternal diabetes. None 
of them became hypoglycemic during the study period. All infants 
were admitted to our neonatal unit within 2 hours after birth. 
None of them had congenital malformations. The study was ap­
proved by the scientific board of the Department of Pediatrics and 
the Ethical Committee of the University Hospital of Leiden. In­
formed parental consent was obtained in all cases.
Determination of Nonprotein-bound Iron and Lipid 
Peroxidation
Blood was collected into heparinized glass tubes and immedi­
ately centrifuged (750 X g, 10 minutes); the plasma was stored 
under argon at ~70°C until analysis. Plasma samples that showed 
pink discoloration (hemolysis) were excluded from the study, 
nonprotein-bound iron in plasma was measured by the bleomycin 
assay.13 Using this assay, the absence of nonprotein-bound iron, ie, 
the presence of iron binding capacity, can be measured as well as 
the presence of nonprotein-bound iron, ie, the lack of iron-binding 
capacity. If nonprotein-bound iron is present, the lower detection 
limit is 0.6 /xM. The glass tubes used to collect the blood did not 
contain detectable amounts of iron. The intra- and interassay 
coefficients of variation of the bleomycin assay are 6.6% and 7.4%, 
respectively. Lipid peroxidation was detected by measuring the 
concentration of TBARS according to the method of Asakawa and 
Matsushita.14 Because bilirubin is known to react with thiobarbi- 
turic acid reagent15 interference was checked by adding bilirubin 
in high concentrations to the reaction medium. To eliminate the 
effect of bilirubin, a correction factor was introduced following the 
method of Thurnham et al:15 measured TBARS (ju-M) -  0.034 
bilirubin (/i,M) — corrected TBARS (/u-M). All TBARS values in this 
study are expressed as corrected TBARS. Preliminary studies 
showed no effect of storage on nonprotein-bound iron or TBARS 
concentration.
Study Design
When blood was withdrawn from the patients for clinical pur­
poses, a small additional sample was taken to determine nonpro- 
tein-bound iron and TBARS. These samples were collected during 
the following time-periods: 0 to 8, 8 to 16, and 16 to 24 hours after 
birth. Mean time (¿ 1  SD) of blood sample collection during the 
subsequent time periods was 4.0 ± 1.2,11.5 ± 2.5, and 21.8 ± 2.0 
hours for control infants; 4.4 ± 2,2,11.7 ± 1.5, and 20.2 ± 2.1 hours 
for moderately asphyxiated infants; and 4.4 ±  1.0,11,6 ± 1.7, and 
18.8 ± 2.0 hours for severely asphyxiated infants, respectively. 
Additional blood samples were taken 24 to 36 hours after birth to 
determine liver enzymes: serum glutamic oxaloacetic transami­
nase (SGOT), serum glutamic pyruvic transaminase (SGPT), and 
lactic acid dehydrogenase (LDH), renal function (creatinine, urea), 
and uric acid levels. Neurologic examinations were performed by 
the attending neonatologist. When the neurologic observations 
were abnormal, the newborn was also examined by a pediatric 
neurologist. Brain tissue damage and abnormal electrocortical 
brain activity were assessed by cranial two-dimensional ultra­
sound, computed tomography, and/or electroencephalogram reg­
istrations, Follow-up at the age of 1 year was evaluated by the Van 
Wiechen neurodevelopmental assessment test, which is used in 
Dutch child health care for children from 4 weeks to 5 years of age. 
It is based on milestones and warning symptoms, such as asym­
metry, dystonia, persistence of primitive reflexes, and hearing or 
visual disturbances as defined by Touwen,16 and on five to eight 
items covering the five fields of development as described by 
Gesell and Amatruda17 (The items were chosen in such a way that 
at least 90% of a healthy population will achieve them by the age 
at examination).
Statistical Analysis
Differences between the perinatal and laboratory data of the 
three groups were assessed by one-way factorial analysis of vari­
ance. When a significant difference was found, analysis of vari­
ance was followed by the Scheffe's procedure for comparison
between the groups. Because of a skewed distribution of the 
nonprotein-bound iron and TBARS data, nonparametric statistics 
were used to analyze these data. Only those infants with obser­
vations during at least two time periods were included in this 
statistical analysis (see "Results")« Differences between the three 
groups within one time period were assessed by the Kruskal- 
Wallis test, followed by the Mann-Whitney U test, to compare 
between each two groups, when a significant difference was 
found. Differences between the three time periods within one 
group were analyzed by the Friedman test, followed by the Wil- 
coxon signed ranks test to compare between each two time peri­
ods, when a significant difference was found.
To investigate if there was an association between the long­
term outcome of the infants in this study and one or more of the 
parameters for organ damage, a stepwise forward logistic regres­
sion (P value to enter = .05; P value to remove -  .10) was 
performed with outcome at 1 year of age (good [normal] or 
adverse [abnormal, death]) as dependent variable and cord/first 
pH, SGOT, SGPT, LDH, creatinine, urea, uric acid and nonprotein- 
bound iron, and TBARS at 0 to 8 hours, 8 to 16 hours, and 16 to 24 
hours as independent variables. Adding or removing variables 
was based on the likelihood criteria.
Results in the text and figures are expressed as mean (± 1 SD) 
or as median with ranges where appropriate. P < .05 were con­
sidered statistically significant.
RESULTS
Patients Characteristics and Laboratory Data
Patients characteristics are shown in Table 1. There 
were no significant differences between the three 
groups regarding b irth  weight or gestational age, 
although the infants of the control group tended to 
have a lower gestational age. Presumptive causes of 
the asphyxiated infants were abruptio placentae (n = 
3), meconium aspiration (n = 6), strangulation of the 
umbilical cord around the neck (n = 3), insufficient 
progression of delivery, resulting in cesarean section 
or vacuum extraction (n = 16), and unknown (n = 2). 
Cord or first capillary pH (within 10 minutes of 
birth) and 5-minute Apgar scores of the severely 
asphyxiated infants were significantly lower than 
those of the m oderately asphyxiated infants, whose 
values were significantly lower than those of the 
control infants. Individual and mean laboratory data 
of all the infants are shown in Fig 1. The SGOT, 
SGPT, LDH, and creatinine concentrations of the 
severely asphyxiated infants were significantly 
higher than those of the moderately asphyxiated and 
control infants. The urea and uric acid concentrations 
of the moderately and severely asphyxiated infants 
were significantly higher than those of the control 
infants.
TABLE 1. Patient Characteristics of the Three Study Groups 
(Means ± 1 SD)*
CONT MA SA
Birth weight (g) 3158 ± 768 3357 ± 479 3413 ±622
GA (wk) 37.5 ± 2.6 39.8 ± 1.8 39.8 ±2.2
Cord/ 1st pH 7.27 ± 0.09 7.02 ± 0.08+ 6.87 ± 0.12+t
Median Apgar at 5 min 9 (7-10) 7 (6-10) 4 (l-8)+±
(range)
* CONT = control group [n = 20]; MA = moderately asphyxiated 
group [n = 15]; SA =  severely asphyxiated group [n = 15]; GA = 
gestational age. 
f P < .05 vs CONT.
$ P <  .05 vs MA.
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Fig 1. Individual and mean (—) plasma concentrations of SCOT, SGPT, LDH, creatinine, urea, and uric acid in the three study groups. 
CONT [O] = control group, (n = 18); MA [ 0 ] = moderately asphyxiated group (n = 13); SA [□] = severely asphyxiated group (n = 13).
Fig 2. Individual and median («*) 
plasma concentrations of nonprotein- 
bound iron (NPBI) in the three study 
groups during the various postnatal 
ages. [OI =  control group (n = 14, 
n = 12 and n = 13 at [0 to 8 hours], [8 
to 16 hours] and [16 to 24 hours]); 
[0] = moderately asphyxiated 
group (n = 10, n = 9, and n = 11 at 0 
to 8 hours, 8 to 16 hours, and 16 to 24 
hours); [□] = severely asphyxiated 
group (n = 12, n = 12, and n = 11 at 
0 to 8 hours, 8 to 16 hours, and 16 to 
24 hours). [□] indicates the individ­
ual plasma concentrations of NPBI of 
the four severely asphyxiated neo­
nates with favorable outcome at 1 
year of age.
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Nonprotein-bound Iron
Figure 2 and Table 2 show the individual concen­
trations of nonprotein-bound iron (medians indi­
cated by the little dash) in the three groups during 
the subsequent postnatal time periods. Nonprotein- 
bound iron was detected in 6/20 (30%) of the control, 
9/15 (60%) of the moderately asphyxiated, and 
12/15 (80%) of the severely asphyxiated infants in at 
least one of the three time periods. The nine control 
infants without detectable nonprotein-bound iron in 
plasma were not different for any patient character­
istic as compared w ith the remaining six control
infants w ith detectable nonprotein-bound iron. 
Moreover, no reason w as found in these six patients 
for the occurrence for nonprotein-bound iron.
In this clinical study it was not always possible to 
obtain a blood sample from each patient during each 
of the time periods (eg, rejection of blood sample 
because of hemolysis, death [severely asphyxiated 
infants] or discharge): 14 control infants (n = 14, n =
12, and n =  13 at 0 to 8 hours, 8 to 16 hours, and 16 
to 24 hours, respectively), 13 m oderately asphyxiated 
infants (n = 10, n = 9, and n  =  11 at 0 to 8 hours, 8 
to 16 hours, and 16 to 24 hours, respectively), and 13
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TABLE 2. Individual Plasma Concentrations of Nonprotein-bound Iron (NPBI) in the Control, Moderately Asphyxiated, and Severely 
Asphyxiated Babies During the Various Postnatal Ages’
n NPBI (/xM) NPBI (fM) NPBI (juM)
Controls Moderately Asphyxiated Severely Asphyxiated
0-8 h 
(n = 14)
8-16 h 
(n -  12)
16-24 h 
(n = 13)
0-8 h 
(n = 10)
8-16 h 
(n = 9)
16-24 h
(n = 11)
0-8 h 
(n = 12)
8-16 h 
(n = 12)
16-24 h
(n = 11)
1 3.0 42.0 28.7 19.6 72.6 21.1 31.1 94.4 68.2
2 13.3 25.3 2.0 1.7 88.6 56.0 65.2 84.7 100.0
3 11.8 4.6 9.3 16.2 0 100.0 86.2 99.4
4 5.8 3.3 5.2 0 0 71.3 99.6 97.6
5 0 0 0 43.0 2.2 89.0 100.0 73.7
6 14.8 13.8 2.3 61.5 81.7 82.9 91.6
7 0 0 20.5 0 Of Of Of
8 0 0 0 0 22.3 32.5
9 0 0 0 0 Of Of
10 0 0 1.2 39.1 26.9 7.3
11 0 0 41.8 48.4 98.9 61.9
12 0 0 57.3 73.6 26.2+ 21.5+
13 0 0 0 0 0+ 0+
14 0 0 0 82.9
15 0 0 97.6
16 0
17 0
18 0
19 3.5
20 0
Median (range) 0 (0-14.8) 0 (0-42.00) 0 (0-28.7) 2.0 (0-43.0) 1.2 (0-88.6) 21.1 (0-73.6) 68.3 (0-100) 83.8 (0-100) 68.2 (0-100]
Mean (±SD) 3.5 ± 5.6 7.4 ± 13.4 3.7 ± 8.0 10.3 ± 14.4 29.1 ± 36.3 27.4 ± 28.9 55.7 ± 37.3$§ 58.7 ± 43.0$ 56.5 ± 41.4:
* The median values with the ranges and the mean (± 1SD) values are indicated at the bottom of the table, 
t  Normal outcome at 1 year of age.
$ P < .05 vs controls.
§ P < .05 vs moderately asphyxyiated (0-8 hours).
severely asphyxiated infants (n = 12, n = 12, and n  =
11 at 0 to 8 hours, 8 to 16 hours, and 16 to 24 hours, 
respectively) had  at least nonprotein-bound iron de­
terminations during  tw o time periods. Patient char­
acteristics and laboratory data of these infants were 
not different from  the original groups. For statistical 
analysis of the data show n in Fig 2 only those infants 
with observations during  at least two time periods 
were included. In the severely asphyxiated infants, 
the plasma concentration of nonprotein-bound iron 
was significantly elevated during the whole study 
period as com pared w ith  the control infants, and 
from 0 to 8 hours as com pared with the moderately 
asphyxiated infants. No significant changes of non­
protein-bound iron concentration were seen between 
the three time periods w ith in  one group.
TBARS
The m edian (range) plasma concentration of 
TBARS for the three groups were as follows: 6.79 
(4.43 through 15.01), 6.36 (4.74 through 11.30), and 
6.35 (4.72 through 17.29) juM at 0 to 8 hours; 7.81 (5.53 
through 10.9), 9.87 (3.60 through 13.89), and 9.50 
(4.27 through 27,54) /uM at 8 to 16 hours; and 7,99 
(6.21 through 11.3), 9.22 (6.01 through 12.32), and 
9.43 (6.32 through 16.58) ¡xM at 16 to 24 hours for 
control, m oderately asphyxiated, and  severely as­
phyxiated infants, respectively. TBARS tended to be 
higher in the asphyxiated infants as compared w ith 
the control infants at 8 to 16 hours and 16 to 24 hours, 
bu t this difference never reached significance. No 
significant changes of TBARS concentration were 
seen betw een the three time periods within one
group. Mean values (±  1 SD) for maximal total bili­
rubin plasma concentrations during the first 24 hours 
of life were 94.8 ±  43.8, 61.8 ±  14.9, and 62.5 ±  41.4
jttM for control, moderately asphyxiated, and se­
verely asphyxiated infants, respectively, and did not 
differ between groups.
Short-term Outcome
Fourteen of the 15 severely asphyxiated infants 
needed assisted ventilation beyond the resuscitation 
period, 9 infants had  convulsions requiring anticon- 
vulsive therapy, 1 infant received an erythrocyte 
transfusion because of a low hemoglobin and two 
needed dopamine medication to treat hypotension 
during the study period. Nine of the 15 severely 
asphyxiated infants developed major neurologic ab­
normalities. All died during the early neonatal pe­
riod after supportive treatment was withdrawn be­
cause of their deteriorating neurologic condition (eg, 
coma, extensive cerebral damage), determined by 
computer tom ography an d /o r  a virtually flat elec­
troencephalogram. A m ong them were those two se­
verely asphyxiated infants excluded from the statis­
tical analysis because of only one blood sample (both 
died in the first 8 hours after birth and had rather 
high nonprotein-bound iron concentrations: 82.9 juM 
and 97.6 fxM). At discharge two of the six surviving 
severely asphyxiated infants had abnormal neuro­
logic examinations (hypo- or hypertonia and little 
spontaneous movement). All the control and moder­
ately asphyxiated infants were neurologically nor­
mal at discharge.
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Fig 3. Individual and median (<-») plasma concentrations of non­
protein-bound iron (NPBI) at 0 to 8 hours after birth in the infants 
with a favorable (n = 26) and an adverse outcome at 1 year of age 
or death (n = 10).
Long-term Outcome
All the control and moderately asphyxiated infants 
were neurologically normal at 1 year of age. Of the 
six surviving severely asphyxiated infants, two 
showed a delayed neurodevelopmental outcome at 1 
year of age. The other four survivors were neurolog­
ically normal at 1 year of age. Three of these infants 
had  no detectable nonprotein-bound iron during the 
study period. Stepwise logistic regression analysis 
w ith outcome at 1 year of age (good [normal] or 
adverse [abnormal, death]) as dependent variable 
and cord/first pH , SGOT, SGPT, LDH, creatinine, 
urea, uric acid, and nonprotein-bound iron and 
TBARS at 0 to 8 hours, 8 to 16 hours, and 16 to 24 
hours as independent variables, revealed that the 
nonprotein-bound iron concentration at 0 to 8 hours 
was the m ost significant variable (P <  .001) and at 
the same time the only variable that entered the 
model. A n increase of the nonprotein-bound iron 
plasma concentrations at 0 to 8 hours w as associated 
with an increased risk for an adverse outcome at 1 
year of age (odds ratio = 1 .12 / juM nonprotein- 
bound iron; 95% confidence interval: 1.00 through 
1.26). Figure 3 shows the individual nonprotein- 
bound iron concentrations (medians indicated by 
small dash) at 0 to 8 hours after birth in the infants 
w ith a good (n = 26) and an adverse outcome (n =
10).
DISCUSSION
To our knowledge, this is the first clinical study 
that has investigated the relation between severity of 
birth asphyxia, plasma concentration of nonprotein- 
bound iron and TBARS, and subsequent neurologic 
outcome. There appeared to be an association be­
tween elevated plasma concentrations of nonprotein- 
bound iron at 0 to 8 hours after birth and  an adverse 
outcome after severe birth asphyxia. Moreover, the 
severely asphyxiated infants w ith no detectable non­
protein-bound iron in their plasma all had  a normal 
neurodevelopmental outcome at 1 year of age. These 
findings m ay imply that nonprotein-bound iron 
plays an im portant role in the pathogenesis of posta- 
sphyxial reperfusion/reoxygenation injury. Interest­
ingly, the association between nonprotein-bound 
iron in plasm a and adverse outcome appeared to be
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lost after 8 hours of age, despite sometimes high 
concentrations of nonprotein-bound iron (Fig 2). Pos­
sibly the reoxygenation of the brain u p o n  early 
reperfusion is an im portant cofactor to generate re­
active oxygen species such as O z* and hydrogen 
oxide, leading to formation of the highly toxic OH* 
radical in the presence of nonprotein-bound iron and 
to brain cell damage.
The ability of plasm a of new born infants to inhibit 
nonprotein-bound iron-induced lipid peroxidation 
in vitro is significantly less com pared w ith  that of 
adult p lasm a .18 Moreover, healthy new born infants 
often have detectable nonprotein-bound iron  in their 
plasma and this seems to be inversely related to their 
gestational age. In  a study  from Moison et al,11 none 
of the adults had detectable nonprotein-bound iron 
in their plasma, bu t 6 /2 4  term  and 10/21 preterm  
infants had  detectable concentrations, w hich makes 
new born infants more susceptible to nonprotein- 
bound  iron-induced oxidative damage. The values 
for nonprotein-bound iron in some of the control 
infants of our study  w ere higher than those previ­
ously reported by u s .11 This m ay be related to their 
som ewhat lower gestational age (11 of the 20  control 
infants had gestational ages between 35.0 and 37.0 
weeks), because preterm  infants do have h igher non­
protein-bound iron values than term infants. With 
respect to the three outlying values of nonprotein- 
bound iron in plasma in the control g roup  (two 
values in the 8 to 16 hours period [25.3 and 42.0 ¡jM]; 
one value in the 16 to 24 hours period [28.7 /xM], see 
also Fig 2) we m ust adm it that we did no t measure 
plasma hemoglobin and have to consider the possi­
bility that the key source of these nonprotein-bound 
iron concentrations could be associated w ith  heme or 
hemoglobin, despite ou r attem pts to clinically ex­
clude this by excluding plasm a samples showing 
pink discoloration. However, the role of heme or 
hemoglobin in detecting nonprotein-bound iron is 
not likely to be of great im portance in our study. In 
a previous s tudy 11 we show ed that despite similar 
hemoglobin concentrations, very different levels of 
nonprotein-bound iron were detected. Furthermore, 
it has been dem onstrated that addition of u p  to 3 m g 
hemoglobin per milliliter plasm a (ie, 46.5 /nmol he­
moglobin per liter plasma) d id  not influence the 
m easurem ent of nonprotein-bound iro n .19 This 
am ount of hemoglobin results in a discoloration of 
plasma that can easily be identified. Because we ex­
cluded samples showing pink discoloration, the 
am ounts of hemoglobin in the rem aining samples 
m ust have been <46.5 ¡jlmol.
The very high nonprotein-bound iron levels in the 
asphyxiated infants could be related to injury- 
induced iron release into the plasma. In the normal 
situation, iron is required for several im portant pro­
cesses: oxygen transport (hemoglobin), mitochon­
drial respiration, proper function of several impor­
tant enzymes, and antibacterial defense and is 
usually firmly bound  to transferrin in plasm a or 
intracellularly to ferritin. These forms of iron  are not 
capable of inducing free radical production  by cata­
lyzing the Haber-Weiss reaction and therefore pro­
vide safe iron transport and storage system s .5 H ow ­
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ever, lowering of the plasm a pH, as occurs during 
ischemia, enables transferrin to liberate its iron, in­
ducing free radical p roduction .20 These free radicals 
are capable of releasing even more iron by mobiliz­
ing it from ferritin .21 By these mechanisms a cascade 
of iron release and free radical production can be 
activated and lead to extensive cell damage. The 
injured cells m ay release their intracellular iron into 
the surrounding environment, thereby further in­
creasing the plasma concentration of nonprotein- 
bound iron. N onprotein-bound iron levels as high as 
21.5 /xmol/L were reported in an adult treated for 
leukemia despite the fact that plasma transferrin was 
only 50% saturated before therapy .22 The authors 
suggest that chemotherapy-induced destruction of 
leukemic cells released sufficient iron to saturate the 
transferrin and  produce high nonprotein-bound iron 
levels. Iron released after anoxic-ischemic damage 
m ay produce even higher nonprotein-bound iron 
concentrations: the latent iron-binding capacity of 
plasma is very limited in the newborn and much less 
of the released iron can be bound .23 We therefore 
suggest that the increased plasma concentration of 
nonprotein-bound iron in our asphyxiated infants 
reflects the increased liberation of nonprotein-bound 
iron from iron-binding proteins a n d /o r  damaged 
cells w ithin the organ systems.
The involvem ent of nonprotein-bound iron in free 
radical m ediated dam age is well established. Halat et 
al24 showed the essential role of nonprotein-bound 
iron in the prom otion of postischemic lipid peroxi­
dation. Others found that local cerebral injection of 
iron salts increased lipid peroxidation ,25 whereas 
lipid peroxidation was inhibited by the iron chelator 
deferoxam ine26 We have recently demonstrated in 
newborn lambs, subjected to severe hypoxic-isch- 
emic reperfusion injury, that there was a very rapid 
increase in nonprotein-bound iron concentration 
w ithin 15 m inutes after the completion of the hy­
poxic-ischemic insult. H ighest values were reached 
at 60 m inutes after completion of the hypoxic- 
ischemia .27
These processes can occur in all im portant organ 
systems,6 which m ay contribute to the elevated liver 
enzymes and abnorm al renal function tests espe­
cially in the severely asphyxiated infants. However, 
the brain m ay be especially at risk for free radical- 
m ediated injury because neuronal membranes are 
very rich in polyunsaturated  fatty acids (sensitive to 
free radical attack) and several areas of the human 
brain are especially rich in iron .5'28 Moreover, the 
iron-binding capacity of cerebrospinal fluid is low 
(low concentration of transferrin) and most of the 
iron will be in its active ferrous form because of a 
high concentration of vitam in C and a low concen­
tration of ceruloplasmin in cerebrospinal fluid .29'30
It can be questioned w hether the increased plasma 
concentration of nonprotein-bound iron in our se­
verely asphyxiated infants is merely a marker of an 
increased leakage from injured cells, or if it is also 
actively inducing peroxidative dam age itself (eg, en­
dothelial damage). Lesnefsky et al31 found that intra­
cellular, but not extracellular, iron administration 
augm ented myocardial reperfusion injury. However,
recent studies show ed that chelating agents confined 
to the intravascular space improved outcome after 
head injury or cardiac arrest.32,33 Another important 
question is w hether the iron in this study will be in 
the active ferrous or less reactive ferric form. Because 
of the high concentration of vitamin C and low con- 
centration of ceruloplasmin in the newborn, the non­
protein-bound iron in these infants is likely to be in 
the highly active ferrous form .18,34'35 We therefore 
suggest that the increased plasma concentration of 
nonprotein-bound iron in this study is more than 
only a marker indicating multi-organ damage and 
m ay have played an important role in the extent of 
the postasphyxial reperfusion injury and the gener­
ally poor neurologic outcome of the severely asphyx­
iated infants. In this respect, studies concerning the 
prevention of free radical-mediated reperfusion in­
jury, which especially focus on scavenging the non- 
protein-bound iron, showed that deferoxamine, the 
prototype chelating agent, has been used success­
fully to dim inish oxidative damage in various stud­
ies.32'33,36 However, caution is required, because de­
feroxamine has shown to be toxic to premature 
baboons .37 O ther promising therapies may be the 
administration of fresh adult plasma (high content of 
unsaturated transferrin) a n d /o r  an exchange trans­
fusion. In newborns, exchange transfusions have 
been shown to lower iron, ferritin, and vitamin C 
levels and raise the concentration of transferrin, 
thereby increasing the latent iron-binding capacity,38 
However, further clinical studies are indicated to 
evaluate the effect of these therapies and to search 
for new agents, which can prevent free radical pro­
duction, scavenge nonprotein-bound iron, and can 
be used safely in newborn infants.
Although the plasma concentration of TBARS in 
the severely asphyxiated infants tended to be higher, 
suggesting an increased lipid peroxidation, these dif­
ferences did no t reach significance. However, it is 
important to realize that TBARS, although they are 
the most frequently quoted evidence for the involve­
m ent of free radicals in hum an disease, do have their 
limitations. They only measure lipid peroxidation, 
although proteins and DNA are more often the tar­
gets of oxidative damage than are lipids. Moreover, 
lipid peroxidation often occurs late in the oxidative 
injury process .39 Therefore, we suggest that oxidative 
damage m ay p lay  a role in the observed association 
between elevated plasma concentrations of nonpro­
tein-bound iron and  an adverse outcome after severe 
b irth  asphyxia.
In summary, the  results of this study suggest a 
relation betw een elevated plasma concentrations of 
nonprotein-bound iron and an adverse outcome at 1 
year of age after severe asphyxia. Although nonpro­
tein-bound iron m ay play an im portant role in the 
pathogenesis of postasphyxial reperfusion injury 
and subsequent neurologic outcome, further study is 
w arranted to evaluate the exact mechanisms of this 
relationship.
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